Tissue microarrays
Open Access
- 1 January 2004
- journal article
- review article
- Published by Taylor & Francis in BioTechniques
- Vol. 36 (1) , 98-105
- https://doi.org/10.2144/04361rv01
Abstract
The identification of disease-related genes is a major focus of modern biomedical research. Recent techniques, including array-based platforms for molecular profiling of disease tissues such as DNA arrays for expression profiling or matrix comparative genomic hybridization, allow for the comprehensive screening of the whole genome in a single experiment. Consequently, thousands of candidate genes have already been identified that may be linked to disease development and progression, and the process of lead discovery continues unimpeded. The evaluation of the clinical value of such leads is challenging because thousands of well-characterized tissue specimens must be analyzed. Tissue microarray (TMA) technology enables high-throughput tissue analyses to keep pace with the rapid process of lead discovery. With this technique, up to 1000 minute tissue samples are brought into an array format and analyzed simultaneously. The TMA technology is a fast, cost-effective, and statistically powerful method that will ... Tissue Microarrays The search for biomarkers indicative of disease state or its progression requires large studies for statistical power. DNA arrays are well suited in scale, but suffer from the disadvantage of measuring a surrogate of protein level. Moreover, archival, fixed tissue samples do not make good sources of cDNA for traditional microarrays. By contrast, tissue microarrays can take full advantage of the vast amount of archived clinical material already available. In an authoritative review, Simon et al. (p. 98) describe the enormous promise of tissue microarrays for applications from drug development to patient prognosis. The authors trace the development of the technology, discuss the issue of tissue representativity, and describe the many applications of the technique. The authors conclude with an analysis of the prospects for automated analysis of tissue microarrays. The result is a comprehensive treatment of a technique that can be expected to be a powerful tool for translational research.Keywords
This publication has 55 references indexed in Scilit:
- HER‐2 and TOP2A coamplification in urinary bladder cancerInternational Journal of Cancer, 2003
- High‐throughput tissue microarray analysis of G1‐cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1The Journal of Pathology, 2003
- Telomerase as a prognostic marker in breast cancer: high‐throughput tissue microarray analysis of hTERT and hTRThe Journal of Pathology, 2002
- Apoptotic Rate in Peripheral T-Cell LymphomasAmerican Journal of Clinical Pathology, 2002
- Prognostic relevance of MAGE‐A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray studyInternational Journal of Cancer, 2002
- Differential Expression of the L-Plastin Gene in Human Colorectal Cancer Progression and MetastasisBiochemical and Biophysical Research Communications, 2001
- Relational Database Structure to Manage High-Density Tissue Microarray Data and Images for Pathology Studies Focusing on Clinical Outcome: The Prostate Specialized Program of Research Excellence ModelThe American Journal of Pathology, 2001
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studiesThe Journal of Pathology, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998